No insider purchase over the last 90 days. The latest was filed 17 Jun 2026.
RSG is a Chemicals company. Its directors and officers file their transactions with ASX. Between 18 October 2025 and 18 October 2026, 7 insiders published 12 filings.
Only purchases show up on the open market, 1 purchase in all worth €9,242, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €9,242 by Gina Jardine, published on 17 June 2026, equal to 0.0006% of the market capitalisation. The buyers include 1 senior executive.
Across the 2,524 companies tracked on its exchange, the median is 3 filings; at 12 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.
The most recent open-market purchase was published on 17 June 2026, 122 days ago.
For comparison within the same sector, see the insider buying recorded at Culp Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate RSG Strong Buy (bullish), based on 5 analysts. Average price target: A$1.79.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
12 of 12 declarations
RSG is a company specializing in the chemical and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 4 filings published between 11 August and 11 October 2026: no open-market purchase or sale filed by an insider. 4 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)